{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:29:10Z","timestamp":1767914950565,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Chongqing Science and Health Joint Medical Research Project","award":["2021MSXM214"],"award-info":[{"award-number":["2021MSXM214"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10528-022-10186-8","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T14:05:59Z","timestamp":1642687559000},"page":"1527-1546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CircPLK1 Acts as a Carcinogenic Driver to Promote the Development of Malignant Pleural Mesothelioma by Governing the miR-1294\/HMGA1 Pathway"],"prefix":"10.1007","volume":"60","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6812-1405","authenticated-orcid":false,"given":"Yuequan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"Suppl 5","key":"10186_CR1","doi-asserted-by":"publisher","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","volume":"26","author":"P Baas","year":"2015","unstructured":"Baas P, Fennell D, Kerr KM, Van Schil PE, Haas RL, Peters S et al (2015) Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v31-39","journal-title":"Ann Oncol"},{"issue":"3","key":"10186_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","volume":"88","author":"P Beckett","year":"2015","unstructured":"Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD (2015) Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 88(3):344\u2013348","journal-title":"Lung Cancer"},{"issue":"6","key":"10186_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10517-018-4084-z","volume":"164","author":"EA Belousova","year":"2018","unstructured":"Belousova EA, Filipenko ML, Kushlinskii NE (2018) Circular RNA: new regulatory molecules. Bull Exp Biol Med 164(6):803\u2013815","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"10186_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.bbrc.2019.06.071","volume":"516","author":"XP Cao","year":"2019","unstructured":"Cao XP, Cao Y, Zhao H, Yin J, Hou P (2019) HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression. Biochem Biophys Res Commun 516(2):457\u2013465","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10186_CR5","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s10620-005-2934-9","volume":"50","author":"ZG Chang","year":"2005","unstructured":"Chang ZG, Yang LY, Wang W, Peng JX, Huang GW, Tao YM et al (2005) Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker. Dig Dis Sci 50(10):1764\u20131770","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10186_CR6","first-page":"291","volume":"8","author":"H Chen","year":"2018","unstructured":"Chen H, Liu L, Li X, Shi Y, Liu N (2018) MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2. Am J Cancer Res 8(2):291\u2013301","journal-title":"Am J Cancer Res"},{"key":"10186_CR7","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.2147\/OTT.S249063","volume":"13","author":"M Chen","year":"2020","unstructured":"Chen M, Xu K, Li B, Wang N, Zhang Q, Chen L et al (2020) HMGA1 Regulates the stem cell-like properties of circulating tumor cells from GIST patients via Wnt\/beta-catenin pathway. Onco Targets Ther 13:4943\u20134956","journal-title":"Onco Targets Ther"},{"key":"10186_CR8","doi-asserted-by":"publisher","first-page":"102815","DOI":"10.1016\/j.critrevonc.2019.102815","volume":"144","author":"M Cinausero","year":"2019","unstructured":"Cinausero M, Rihawi K, Cortiula F, Follador A, Fasola G, Ardizzoni A (2019) Emerging therapies in malignant pleural mesothelioma. Crit Rev Oncol Hematol 144:102815","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10186_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41419-018-0683-x","volume":"9","author":"F Fu","year":"2018","unstructured":"Fu F, Wang T, Wu Z, Feng Y, Wang W, Zhou S et al (2018) HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration\/invasion via targeting miR-221\/222 in cervical cancer. Cell Death Dis 9(6):594","journal-title":"Cell Death Dis"},{"issue":"4","key":"10186_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/107327480601300402","volume":"13","author":"R Ismail-Khan","year":"2006","unstructured":"Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR (2006) Malignant pleural mesothelioma: a comprehensive review. Cancer Control 13(4):255\u2013263","journal-title":"Cancer Control"},{"issue":"2","key":"10186_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","volume":"13","author":"TG Johnson","year":"2018","unstructured":"Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB et al (2018) Dysregulated expression of the microRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma. J Thorac Oncol 13(2):258\u2013272","journal-title":"J Thorac Oncol"},{"key":"10186_CR12","doi-asserted-by":"publisher","DOI":"10.23812\/20-10A","author":"XQ Kan","year":"2020","unstructured":"Kan XQ, Li YB, He B, Cheng S, Wei Y, Sun J (2020) MiR-1294 acts as a tumor inhibitor in cervical cancer by regulating FLOT1 expression. J Biol Regul Homeost Agents. https:\/\/doi.org\/10.23812\/20-10A","journal-title":"J Biol Regul Homeost Agents"},{"issue":"9","key":"10186_CR13","first-page":"1996","volume":"6","author":"N Khodayari","year":"2016","unstructured":"Khodayari N, Mohammed KA, Lee H, Kaye F, Nasreen N (2016) MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells. Am J Cancer Res 6(9):1996\u20132009","journal-title":"Am J Cancer Res"},{"issue":"10","key":"10186_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","volume":"14","author":"T Klonisch","year":"2008","unstructured":"Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K et al (2008) Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14(10):450\u2013460","journal-title":"Trends Mol Med"},{"issue":"10","key":"10186_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2217\/epi-2019-0093","volume":"11","author":"Y Kong","year":"2019","unstructured":"Kong Y, Yang L, Wei W, Lyu N, Zou Y, Gao G et al (2019) CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Epigenomics 11(10):1163\u20131176","journal-title":"Epigenomics"},{"issue":"1","key":"10186_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12935-020-01694-x","volume":"20","author":"G Lin","year":"2020","unstructured":"Lin G, Wang S, Zhang X, Wang D (2020) Circular RNA circPLK1 promotes breast cancer cell proliferation, migration and invasion by regulating miR-4500\/IGF1 axis. Cancer Cell Int 20(1):593","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10186_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000374056","volume":"36","author":"K Liu","year":"2015","unstructured":"Liu K, Li L, Rusidanmu A, Wang Y, Lv X (2015) Down-regulation of MiR-1294 is related to dismal prognosis of patients with esophageal squamous cell carcinoma through elevating C-MYC expression. Cell Physiol Biochem 36(1):100\u2013110","journal-title":"Cell Physiol Biochem"},{"key":"10186_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1476-4598-13-119","volume":"13","author":"A Renganathan","year":"2014","unstructured":"Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I et al (2014) GAS5 long non-coding RNA in malignant pleural mesothelioma. Mol Cancer 13:119","journal-title":"Mol Cancer"},{"issue":"2","key":"10186_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11523-017-0476-7","volume":"12","author":"T Robb","year":"2017","unstructured":"Robb T, Reid G, Blenkiron C (2017) Exploiting microRNAs as cancer therapeutics. Target Oncol 12(2):163\u2013178","journal-title":"Target Oncol"},{"issue":"12","key":"10186_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/ijbs.22531","volume":"13","author":"M Wang","year":"2017","unstructured":"Wang M, Yu F, Wu W, Zhang Y, Chang W, Ponnusamy M et al (2017) Circular RNAs: a novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci 13(12):1497\u20131506","journal-title":"Int J Biol Sci"},{"issue":"Suppl 6","key":"10186_CR21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12864-017-4029-3","volume":"18","author":"T Xu","year":"2017","unstructured":"Xu T, Wu J, Han P, Zhao Z, Song X (2017) Circular RNA expression profiles and features in human tissues: a study using RNA-seq data. BMC Genom 18(Suppl 6):680","journal-title":"BMC Genom"},{"key":"10186_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2147\/OTT.S232718","volume":"13","author":"Q Yuan","year":"2020","unstructured":"Yuan Q, Yu H, Chen J, Song X, Sun L (2020) Antitumor effect of miR-1294\/pyruvate kinase M2 signaling cascade in osteosarcoma cells. Onco Targets Ther 13:1637\u20131647","journal-title":"Onco Targets Ther"},{"issue":"10026","key":"10186_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D et al (2016) Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 387(10026):1405\u20131414","journal-title":"Lancet"},{"issue":"1","key":"10186_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13046-019-1307-8","volume":"38","author":"R Zanin","year":"2019","unstructured":"Zanin R, Pegoraro S, Ros G, Ciani Y, Piazza S, Bossi F et al (2019) HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1. J Exp Clin Cancer Res 38(1):313","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-022-10186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-022-10186-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-022-10186-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T22:06:40Z","timestamp":1663106800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-022-10186-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10186"],"URL":"https:\/\/doi.org\/10.1007\/s10528-022-10186-8","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"26 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}